Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 85

Sort by

Sort Order Select

Journal Articles

Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy

Philip Choi, Charlotte Bradbury, Tomas Jose Gonzalez-Lopez, Muhlis Cem Ar, Karolin Trautmann-Grill, Mathias Rummel, Alessandra Borchiellini, Nicola Cooper, Fernando Chuliber, Rushad Patell, Blanca Sanchez, Patrick Urban, Alex Allepuz, Fabienne Le Gac, Renxin Lin, David Kuter

Blood (2025) 146 (Supplement 1): 844.

https://doi.org/10.1182/blood-2025-844

Published: 2025

Journal Articles

The safety and efficacy of pirtobrutinib in adults with immune thrombocytopenia: A phase 1/2 dose-finding study in progress

Catherine Broome, Tomas Jose Gonzalez-Lopez, Ananya Guntur, Chunxiao Wang, Sasha Amdur, James Pauff, Waleed Ghanima

Blood (2025) 146 (Supplement 1): 8231.

https://doi.org/10.1182/blood-2025-8231

Published: 2025

Journal Articles

Impact of CAR-T cells expansion and tumor burden on the outcome after inotuzumab ozogamicin as bridging therapy in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia.

Patricia Alcalde-Mellado, Victoria Ruiz-Maldonado, Javier Delgado Serrano, Laura Perez-Ortega, Marta Reinoso -Segura, Luzalba Sanoja Flores, Belén Sierro, Estefania Garcia-Guerrero, Concepción Pérez de Soto, José María Pérez Hurtado, José González-Campos, José Antonio Pérez-Simón, Agueda Molinos-Quintana, Teresa Caballero

Blood (2025) 146 (Supplement 1): 2324.

https://doi.org/10.1182/blood-2025-2324

Published: 2025

Journal Articles

Combination of genetics at baseline and clearance of MRD to assign the post-remission treatment of patients with Philadelphia-negative ACUTE lymphoblastic leukemia. FINAL results of pethema LAL19 trial

Anna Torrent, Mireia Morgades, Susana Barrera, Jordi Ribera, Eulàlia Genescà, José González-Campos, Nuria Martinez-Cibrian, Pau Montesinos, Alberto Hernández-Sánchez, Pere Barba, Edgar Zapico, Ricardo Sanchez, Marta Sitges Arriaga, Clara Maluquer Artigal, Esperanza Such, Carmen Botella, Maria Queipo De Llano, Mónica Cabrero Calvo, Ana Maria Vicent Castelló, Paula Lopez de Ugarriza, Mar Tormo, Bernardo Gonzalez Gonzalez, Irene García-Cadenas, Carlos Rodriguez Medina, Pilar Martínez-Sánchez, Arancha Bermúdez, Ignacio Gómez-Centurión, María Herrero García, Juana Ciudad, María Hermosín-Ramos, Josefina Serrano, Jose Angel Raposo Puglia, Laura Solán Blanco, Verónica Roldán Galiacho, María Almudena De Laiglesia Lorenzo, Lucía Gómez Pérez, María Solé Rodriguez, Mará Sol Casado Calderón, Laura Llorente González, Daniel Barrios Decoud, Ferran Vall-Llovera Calmet, Lorenzo Algarra, María Lourdes Amador Barciela, Raimundo Garcia, Antonia Cladera Serra, Juan Miguel Bergua Burgues, Isabel Granada, Jesus Maria Hernandez Rivas, Alberto Orfao, Josep-Maria Ribera

Blood (2025) 146 (Supplement 1): 5121.

https://doi.org/10.1182/blood-2025-5121

Published: 2025

Journal Articles

Efficacy of single-agent subcutaneous blinatumomab in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase 1/2 dose expansion study with extended follow-up

Blood (2025) 146 (Supplement 1): 5117.

https://doi.org/10.1182/blood-2025-5117

Published: 2025

Journal Articles

Excellent prognosis for adult patients with Philadelphia chromosome-negative ALL with standard genetic risk and EARLY clearance of MRD. sub-analysis of pethema LAL19 trial

Blood (2025) 146 (Supplement 1): 1564.

https://doi.org/10.1182/blood-2025-1564

Published: 2025

Journal Articles

Prognostic Impact of the Genetic Risk at Baseline Associated to the MRD Clearance in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia. Preliminary Results of Pethema LAL19 Trial

Blood (2024) 144 (Supplement 1): 962.

https://doi.org/10.1182/blood-2024-205124

Published: 2024

Journal Articles

A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3

David J Kuter, Tomas Jose Gonzalez Lopez, Karolin Trautmann-Grill, Mathias J. Rummel, Philip Young-Ill Choi, Alessandra Borchiellini, Muhlis Cem Ar, Huyen Tran, Tienan Zhu, Jae-Ho Yoon, Nichola Cooper, Thomas Stauch, Pinar Tarkun, Fabienne Le Gac, Alex Allepuz, Patrick Urban, Renxin Lin, Charlotte A. Bradbury

Blood (2024) 144 (Supplement 1): 710.

https://doi.org/10.1182/blood-2024-201418

Published: 2024

Journal Articles

Similar Outcome of Adolescents and Young Adults (AYA) and Older Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) without Philadelphia Chromosome (Ph-) Included in the Pethema LAL-2019 Trial

Blood (2024) 144 (Supplement 1): 1437.

https://doi.org/10.1182/blood-2024-207954

Published: 2024

Journal Articles

Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain

Blood (2024) 144 (Supplement 1): 2555.

https://doi.org/10.1182/blood-2024-202555

Published: 2024

Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón

Blood (2024) 144 (6): 646–656.

https://doi.org/10.1182/blood.2024024250

Published: 2024

Journal Articles

VAYHIT3: An Open-Label, Single-Arm, Phase II Trial to Evaluate the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (ITP) Previously Treated with at Least 1 Corticosteroid and 1 Thrombopoietin Receptor Agonist (TPO-RA)

David J Kuter, Charlotte A. Bradbury, Alex Allepuz, Nadège Pfender, Jens Haenig, Claus Nowak, Tomas Jose Gonzalez-Lopez

Blood (2023) 142 (Supplement 1): 5455.

https://doi.org/10.1182/blood-2023-180005

Published: 2023

Journal Articles

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

Blood (2023) 142 (Supplement 1): 2591.

https://doi.org/10.1182/blood-2023-190511

Published: 2023

Journal Articles

Role of Allogeneic Stem Cell Transplantation in Preventing Relapse in Adult BCR::ABL1-like Acute Lymphoblastic Leukemia

Blood (2023) 142 (Supplement 1): 1461.

https://doi.org/10.1182/blood-2023-186265

Published: 2023

Journal Articles

Identification of Novel Ways Disrupting Platelet-Fibrinogen Interactions

Siobhan Laken Branfield, Xariana Vales, Susan LaGrand, Jose González, Pearl Akamine, Abel Baerga, Yadira Cantres, Loyda Melendez, Colin Wu, Anthony Washington

Blood (2023) 142 (Supplement 1): 5437.

https://doi.org/10.1182/blood-2023-187256

Published: 2023

Journal Articles

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

Bruno Fattizzo, Marta Bortolotti, Norma N. Fantini, Andreas Glenthøj, Marc Michel, Mariasanta Napolitano, Simona Raso, Frederick Chen, Vickie McDonald, Irina Murakhovskaya, Josephine Mathilde Iris Vos, Andrea Patriarca, Maria Eva Mingot-Castellano, Giulio Giordano, Margherita Scarrone, Tomás José González-López, Laura Trespidi, Daniele Prati, Wilma Barcellini

Blood (2023) 141 (16): 2016–2021.

https://doi.org/10.1182/blood.2022018890

Published: 2023

Includes: Supplemental data

Journal Articles

Stem Cells and Leukemic Stem Cells As a Prognostic Factor in Acute Myeloid Leukemia

Olga Pérez-López, Marta Reinoso Segura, Clara B. Calderon Garcia, Noelia González-Carrasco, María Solé, Eduardo Rodriguez Arboli, Concepción Prats-Martín, Jose González Campos, Jose A. Perez-Simon, Teresa Caballero

Blood (2022) 140 (Supplement 1): 3446–3447.

https://doi.org/10.1182/blood-2022-169528

Published: 2022

Journal Articles

Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients

Jorge Labrador, Maria Victoria Cuevas, Cristina Alonso-Madrigal, Pablo Zubiaur, Raul Azibeiro, Beatriz Cuevas, Rodolfo Alvarez, Francisco Javier Diaz-Galvez, Tomas Jose Gonzalez-Lopez, Raquel Alcaraz, Gina Paola Mejía-Abril, Javier Loscertales, Francisco Abad, Miriam Saiz-Rodríguez

Blood (2022) 140 (Supplement 1): 12405–12406.

https://doi.org/10.1182/blood-2022-163176

Published: 2022

Journal Articles

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience

Bruno Fattizzo, Nicola Cecchi, Marta Bortolotti, Giulio Giordano, Andrea Patriarca, Andreas Glenthøj, Silvia Cantoni, Marco Capecchi, Frederick Chen, Maria Eva Mingot-Castellano, Mariasanta Napolitano, Henrik Frederiksen, Tomàs José Gonzaléz-Lopez, Wilma Barcellini

Blood (2022) 140 (7): 789–792.

https://doi.org/10.1182/blood.2022016818

Published: 2022

Journal Articles

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Blood (2022) 139 (10): 1588–1592.

https://doi.org/10.1182/blood.2021014124

Published: 2022

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy

The safety and efficacy of pirtobrutinib in adults with immune thrombocytopenia: A phase 1/2 dose-finding study in progress

Impact of CAR-T cells expansion and tumor burden on the outcome after inotuzumab ozogamicin as bridging therapy in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia.

Combination of genetics at baseline and clearance of MRD to assign the post-remission treatment of patients with Philadelphia-negative ACUTE lymphoblastic leukemia. FINAL results of pethema LAL19 trial

Efficacy of single-agent subcutaneous blinatumomab in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase 1/2 dose expansion study with extended follow-up

Excellent prognosis for adult patients with Philadelphia chromosome-negative ALL with standard genetic risk and EARLY clearance of MRD. sub-analysis of pethema LAL19 trial

Prognostic Impact of the Genetic Risk at Baseline Associated to the MRD Clearance in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia. Preliminary Results of Pethema LAL19 Trial

A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3

Similar Outcome of Adolescents and Young Adults (AYA) and Older Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) without Philadelphia Chromosome (Ph-) Included in the Pethema LAL-2019 Trial

Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

VAYHIT3: An Open-Label, Single-Arm, Phase II Trial to Evaluate the Efficacy and Safety of Ianalumab in Patients with Primary Immune Thrombocytopenia (ITP) Previously Treated with at Least 1 Corticosteroid and 1 Thrombopoietin Receptor Agonist (TPO-RA)

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

Role of Allogeneic Stem Cell Transplantation in Preventing Relapse in Adult BCR::ABL1-like Acute Lymphoblastic Leukemia

Identification of Novel Ways Disrupting Platelet-Fibrinogen Interactions

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

Stem Cells and Leukemic Stem Cells As a Prognostic Factor in Acute Myeloid Leukemia

Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only